Template:SubstanceBox: Difference between revisions
>Kenan |
>Kenan m Force the display of the safe use box, remove caption field from substance box |
||
Line 322: | Line 322: | ||
<tr> | <tr> | ||
<td colspan="2"> | <td colspan="2"> | ||
<table class="ROATable pw-disclaimer" width="100%"> | |||
<tr> | |||
<td class="ROACaption" colspan="2"> | |||
{{Preamble/SubstanceSafeUse}} | |||
</td> | |||
</tr> | |||
</table> | |||
<!-- Inhaled --> | <!-- Inhaled --> | ||
Line 476: | Line 484: | ||
<th class="ROASubHeader" colspan="2">[[Dosage]]</th> | <th class="ROASubHeader" colspan="2">[[Dosage]]</th> | ||
</tr> | </tr> | ||
{{#if: {{{OralROA_Bioavailability}}} | | {{#if: {{{OralROA_Bioavailability}}} | | ||
Line 544: | Line 545: | ||
<th class="ROASubHeader" colspan="2">[[Dosage]]</th> | <th class="ROASubHeader" colspan="2">[[Dosage]]</th> | ||
</tr> | </tr> | ||
{{#if: {{{BuccalROA_Bioavailability}}} | | {{#if: {{{BuccalROA_Bioavailability}}} | | ||
Line 612: | Line 606: | ||
<th class="ROASubHeader" colspan="2">[[Dosage]]</th> | <th class="ROASubHeader" colspan="2">[[Dosage]]</th> | ||
</tr> | </tr> | ||
{{#if: {{{SublingualROA_Bioavailability}}} | | {{#if: {{{SublingualROA_Bioavailability}}} | | ||
Line 681: | Line 668: | ||
<th class="ROASubHeader" colspan="2">[[Dosage]]</th> | <th class="ROASubHeader" colspan="2">[[Dosage]]</th> | ||
</tr> | </tr> | ||
{{#if: {{{InsufflatedROA_Bioavailability}}} | | {{#if: {{{InsufflatedROA_Bioavailability}}} | | ||
Line 752: | Line 732: | ||
<th class="ROASubHeader" colspan="2">[[Dosage]]</th> | <th class="ROASubHeader" colspan="2">[[Dosage]]</th> | ||
</tr> | </tr> | ||
{{#if: {{{RectalROA_Bioavailability}}} | | {{#if: {{{RectalROA_Bioavailability}}} | | ||
Line 820: | Line 793: | ||
<th class="ROASubHeader" colspan="2">[[Dosage]]</th> | <th class="ROASubHeader" colspan="2">[[Dosage]]</th> | ||
</tr> | </tr> | ||
{{#if: {{{TransdermalROA_Bioavailability}}} | | {{#if: {{{TransdermalROA_Bioavailability}}} | | ||
Line 890: | Line 856: | ||
<th class="ROASubHeader" colspan="2">[[Dosage]]</th> | <th class="ROASubHeader" colspan="2">[[Dosage]]</th> | ||
</tr> | </tr> | ||
{{#if: {{{SubcutaneousROA_Bioavailability}}} | | {{#if: {{{SubcutaneousROA_Bioavailability}}} | | ||
Line 960: | Line 919: | ||
<th class="ROASubHeader" colspan="2">[[Dosage]]</th> | <th class="ROASubHeader" colspan="2">[[Dosage]]</th> | ||
</tr> | </tr> | ||
{{#if: {{{IntramuscularROA_Bioavailability}}} | | {{#if: {{{IntramuscularROA_Bioavailability}}} | | ||
Line 1,029: | Line 981: | ||
<th class="ROASubHeader" colspan="2">[[Dosage]]</th> | <th class="ROASubHeader" colspan="2">[[Dosage]]</th> | ||
</tr> | </tr> | ||
{{#if: {{{IntravenousROA_Bioavailability}}} | | {{#if: {{{IntravenousROA_Bioavailability}}} | |